Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
Bio2RDF identifier
NCT00521885
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00521885
identifiers.org URI
acronym [clinicaltrials_vocabulary:acronym]
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
A total of 50 patients ...... arge from
the hospital.
brief title [clinicaltrials_vocabulary:brief-title]
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2008-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
A total of 50 patients ...... ith LE duplex ultrasonogram).
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2007-08-24T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
Bleeding rates
Prophylaxis for deep vein thrombosis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-09-18T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00521885
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Arixtra(Fondaparinux) vs. Love ...... lly Ill, Non-surgical Patients
org study id [clinicaltrials_vocabulary:org-study-id]
LVH IRB# 2-20070508
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2008-09-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2007-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-09-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Study stopped due to lack of accrual
identifier
clinicaltrials:NCT00521885
title
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
@en